Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure

Summary by Globe Newswire
Durham, N.C., April 01, 2026 (GLOBE NEWSWIRE) -- Final participant randomized in the GenePHIT Phase 2 clinical trial assessing safety and efficacy...

6 Articles

The Toronto StarThe Toronto Star
+5 Reposted by 5 other sources
Lean Left

AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure

Durham, N.C., April 01, 2026 (GLOBE NEWSWIRE) -

·Toronto, Canada
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 80% of the sources lean Left
80% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Simcoe.com broke the news in on Wednesday, April 1, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Durham, North Carolina icon

Durham, North Carolina

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal